The majority of dominant HCAs are polyglutamine disorders arising from repeat-expansion triplets (SCA 1, SCA2, MJD/SCA3, SCA6 and SCA7), with the expansion size being partially responsible for age of onset, severity and clinical progression [2,3]. The gene discussed is ATXN2; the disease is Spinocerebellar ataxia type 3.